On the other hand, SREBP-1c and patatin-like phospholipase domain-containing protein 3 (PNPLA-3) pathways may affect the progression of NASH [39,40]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatohepatitis.